Association study of polymorphisms in the receptor for advanced glycation end-products (RAGE) gene with susceptibility and prognosis of heart failure

Gene

Volumn 510, Issue 1, 2012, Pages 7-13

  Cohen, Carolina Rodrigues ^a   Diel, Vanessa Backes Nascimento ^b   La Porta, Vanessa Laubert ^a   Rohde, Luís Eduardo ^a   Biolo, Andréia ^a   Clausell, Nadine ^a   dos Santos, Kátia Gonçalves ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Diabetes; Heart failure; Polymorphisms; Receptor for advanced glycation end products (RAGE)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; AGED; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; INDEL MUTATION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION MAPPING; SURVIVAL; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALLELES; BRAZIL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, IMMUNOLOGIC;

EID: 84866911603     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.08.043     Document Type: Article

References (39)

1. Abramson J.H., Gahlinger P.M. Computer Programs for Epidemiologic Analyses: PEPI version 4.0 (available from: http://www.sagebrushpress.com/pepibook.html).
2. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31:S55-S60.
3. Aydoǧan H.Y., Küçükhüseyin O., Tekeli A., Isbir T. Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients. Genet. Test. Mol. Biomarkers 2012, 16:134-137.
4. Boiocchi C., et al. Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated?. Rejuvenation Res. 2011, 14:67-73.
5. Davis R.C., Hobbs F.D.R., Lip G.Y.H. ABC of heart failure: history and epidemiology. BMJ 2000, 20:39-42.
6. Dorn G.W. Genetics of common forms of heart failure. Curr. Opin. Cardiol. 2011, 26:204-208.
7. Engelen L., et al. The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies. J. Hypertens. 2010, 28:285-293.
8. Falcone C., et al. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int. J. Mol. Med. 2004, 14:1061-1064.
9. Falcone C., et al. The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement. Clin. Chim. Acta 2005, 354:111-116.
10. Falcone C., et al. The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement. Int. J. Immunopathol. Pharmacol. 2007, 20:771-777.
11. Falcone C., et al. The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Arch. Med. Res. 2008, 39:320-325.
12. Hosking L., et al. Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur. J. Hum. Genet. 2004, 12:395-399.
13. Hudson B.I., Stickland M.H., Futers T.S., Grant P.J. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001, 50:1505-1511.
14. Hudson B.I., Stickland M.H., Futers T.S., Grant P.J. Study of the -429 T/C and -374 T/A receptor for advanced glycation end products promoter polymorphisms in diabetic and nondiabetic subjects with macrovascular disease. Diabetes Care 2001, 24:2004.
15. Jessup M., et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J. Am. Coll. Cardiol. 2009, 53:1343-1382.
16. Kalea A.Z., Schmidt A.M., Hudson B.I. RAGE: a novel biological and genetic marker for vascular disease. Clin. Sci. 2009, 116:621-637.
17. Kirbis J., Milutinović A., Steblovnik K., Teran N., Terzić R., Zorc M. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Coll. Antropol. 2004, 28:611-616.
18. Koyama Y., et al. Soluble receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure. J. Card. Fail. 2008, 14:133-139.
19. Kucukhuseyin O., Aydogan H.Y., Isbir C.S., Isbir T. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease. In Vivo 2009, 23:949-954.
20. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991, 19:5444.
21. Lewontin R.C. On measures of gametic disequilibrium. Genetics 1988, 120:849-852.
22. Lu L., et al. Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients. Clin. Chim. Acta 2008, 396:33-37.
23. Nielsen D.M., Ehm M.G., Weir B.S. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am. J. Hum. Genet. 1999, 63:1531-1540.
24. Park S., Yoon S.J., Tae H.J., Shim C.Y. RAGE and cardiovascular disease. Front. Biosci. 2011, 16:486-497.
25. Peng W.H., et al. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. Arch. Med. Res. 2009, 40:393-398.
26. Pettersson-Fernholm K., et al. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 2003, 52:891-894.
27. Picheth G., Costantini C.O., Pedrosa F.O., Martinez T.L.R., de Souza E.M. The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients. Clin. Chem. Lab. Med. 2007, 45:1268-1272.
28. Poon P.Y., Szeto C.C., Chow K.M., Kwan B.C., Li P.K. Relation between polymorphisms of receptor for advanced glycation end products (RAGE) and cardiovascular diseases in Chinese patients with diabetic nephropathy. Clin. Nephrol. 2010, 73:44-50.
29. Raposeiras-Roubín S., et al. Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: new roles for soluble RAGE. Eur. J. Heart Fail. 2010, 12:1092-1100.
30. Raposeiras-Roubín S., et al. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score. Am. J. Cardiol. 2011, 107:938-944.
31. Roger V.L., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
32. Santos K.G., Canani L.H., Gross J.L., Tschiedel B., Souto K.E.P., Roisenberg I. The -374 allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol. Genet. Metab. 2005, 85:149-156.
33. Shim C.Y., et al. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population. Cardiology 2007, 107:261-268.
34. Stephens M., Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing data imputation. Am. J. Hum. Genet. 2005, 76:449-462.
35. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68:978-989.
36. Torres M.C., et al. Polymorphisms of the promoter and exon 3 of the receptor for advanced glycation end products (RAGE) in Euro- and Afro-Brazilians. Int. J. Immunogenet. 2012, 39:155-160.
37. Wang L.J., Lu L., Zhang F.R., Chen Q.J., de Caterina R., Shen W.F. Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure. Eur. J. Heart Fail. 2011, 13:440-449.
38. Yan S.F., Ramasamy R., Schmidt A.M. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease. Expert Rev. Mol. Med. 2009, 11:e9. 10.1017/S146239940900101X.
39. Yoon S.J., et al. Association of RAGE gene polymorphisms with coronary artery disease in the Korean population. Coron. Artery Dis. 2007, 18. 10.1097/MCA.0b013e3280105b4d.